Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Mineralys Therapeutics, Inc. (MLYS) had Return on Investments of -92.97% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-177.81M |
|
-- |
|
-- |
|
$192.40M |
|
$-192.40M |
|
$14.59M |
|
$-177.81M |
|
$-177.81M |
|
$-177.81M |
|
$-177.81M |
|
$-177.81M |
|
$-177.81M |
|
$-192.40M |
|
$-192.36M |
|
48.54M |
|
48.54M |
|
$-3.66 |
|
$-3.66 |
|
| Balance Sheet Financials | |
$205.35M |
|
$0.05M |
|
$0.55M |
|
$205.90M |
|
$14.65M |
|
-- |
|
-- |
|
$14.65M |
|
$191.26M |
|
$191.26M |
|
$191.26M |
|
49.82M |
|
| Cash Flow Statement Financials | |
$-166.31M |
|
$114.96M |
|
$116.14M |
|
$49.30M |
|
$114.09M |
|
$64.79M |
|
$11.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-166.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-92.97% |
|
-92.97% |
|
-86.36% |
|
|
Return on Investments |
-92.97% |
$3.84 |
|
$-3.43 |
|
$-3.43 |
|